BOVIMAST DC, 500 MG CLOXACILLIN/SYRINGE, INTRAMAMMARY SUSPENSION
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
02-05-2024
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
CLOXACILLIN BENZATHINE
Available from:
Cross Vetpharm Group Limited
ATC code:
QJ51CF
INN (International Name):
CLOXACILLIN BENZATHINE
Dosage:
500 mg/syringe
Pharmaceutical form:
intramammary Suspension
Prescription type:
POM
Therapeutic group:
Bovine
Therapeutic area:
Beta-lactamase resistant penicillins
Therapeutic indications:
Antibacterial
Authorization status:
Authorised
Authorization date:
2004-07-08
Summary of Product characteristics
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Bovimast DC, 500 mg cloxacillin/syringe, Intramammary suspension
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 3 g syringe contains:
ACTIVE SUBSTANCE:
Cloxacillin (as Cloxacillin Benzathine)
500 mg
EXCIPIENTS:
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Intramammary suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cows
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For routine use in cows at drying off, to treat existing intramammary infections and to assist in preventing new infections
occurring during the dry period. Bovimast DC contains cloxacillin which is active against the following major pathogens
associated with mastitis: Penicillin resistant and sensitive _Staphylococci _spp., _Micrococci, Streptococcus agalactiae _and
_Corynebacterium _spp.
4.3 CONTRAINDICATIONS
Do not use in lactating cows.
Do not use within 28 days of calving.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 11/07/2012_
_CRN 7013024_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible,
therapy should be based on local (regional, farm level) epidemiological information about susceptibility of the target
bacteria.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS
Penicillin and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin contact.
Hypersensitivity to penicillin may lead to cross sensitivity to cephalo
Read the complete document
